Latest Technology Platform News

ANZ moves to fully own the ANZ Worldline joint venture by acquiring Worldline S.A’s 51% share for $89 million, aiming to deepen its transaction banking services as part of its 2030 strategy.

Nexsen Limited has cleared a major FDA regulatory hurdle for its StrepSure rapid Group B Streptococcus test, confirmed a clear 510(k) submission pathway, and secured over A$1.7 million in non-dilutive grants to expand clinical validation and market rollout in Asia-Pacific and neonatal diagnostics.

Way2VAT reported a 95% surge in Q1 FY26 revenue to $2.05 million, driven by its RBC acquisition and expanding client base, while preparing to launch an e-invoicing platform integrating AI-powered APAI technology.

Butn Limited has signed a memorandum of understanding with a major global bank to launch buyer-led supply chain finance programs in Australia, leveraging Butn’s proprietary platform and the bank’s funding capacity.

Firebird Metals has locked in exclusive global rights to key LMFP patents through 2045 and commissioned lithium-manganese-rich cathode equipment, progressing its Australian Demonstration Plant with a $2 million ARENA grant.

Adisyn has confirmed a major graphene breakthrough compatible with semiconductor manufacturing and secured exclusive radar absorption rights, backed by a $14 million placement led by top institutional investors.

Ovanti Limited is issuing a bonus tranche of Loyalty Options to shareholders at no cost, exercisable at a modest $0.025, potentially raising close to $1 million if fully converted.

Adisyn Ltd has landed a A$14 million placement led by heavyweight institutional investors following two major graphene technology milestones in semiconductors and stealth drone materials.

Noxopharm reports preclinical data revealing SOF-SKN’s active ingredient remains in skin tissues for about 3.5 days with minimal systemic absorption, supporting less frequent dosing and sustained activity for cutaneous lupus treatment.

Invion Limited is broadening its non-melanoma skin cancer trial to include basal cell carcinoma patients following encouraging safety and efficacy data from squamous cell carcinoma cohorts, targeting the largest skin cancer segment.

MA Financial Group reported a 44% year-on-year jump in assets under management to $14.8 billion in 1Q26, underpinned by strong lending growth and transactional activity despite asset sales and market volatility.

Pantera Minerals has seen a 37% uplift in the valuation of its EnergyX stake following an increase in EnergyX’s Regulation A raise price to US$13 per share, reflecting operational progress and stronger market confidence.